ECM Weekly (29 Mar 2020) - Wuxi AppTec, Kintor Pharma, Softbank Group-Driven Placements and More!
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We...
335 Views
Wuxi Apptec (药明康德) Proposed USD1.7bn Placement: Liquidity Matters
Wuxi Apptec is planning to sell both A-share and H-share in a private placement to raise up to USD 1.7 billion. The stock has performed well since...
466 Views
SH/SZ Connect Flows: $6bn Outflows, Walvax, Wuxi Apptec, Dahua
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
281 Views
Hepalink Pharma IPO Initiation: Take a Chance on Me
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
719 Views
SH/SZ Connect Flows: Moutai, Shanghai Intl Airport, Wuxi AppTec
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
233 Views